PATENT CLAIM ANALYSIS

Application Number: 15918117
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["424", "130100"]

Abstract:
The present invention encompasses methods and compositions for  Ureaplasma  infection prevention and/or treatment. In specific cases, the invention concerns vaccines for  Ureaplasma , including DNA vaccines. In certain embodiments, the invention regards vaccines directed towards the multiple-banded antigen(s) of  Ureaplasma.

Claim (Index 4):
The vaccine of  claim 3 , wherein the antigen is urease, UU376 gene product, virulence gene product, or urea transporter, or wherein the polynucleotide comprises MBA N-terminal paralogs, 16S rRNA, the area upstream of the Urease A gene, the Urease A-Urease B spacer, the Urease B-Urease C spacer, or the 16S-23S rRNA intergenic spacer region.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 90.0
- Lexical Diversity: 1.41176
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14968074', '14114703', '15674591', '14149670', '15317021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7071212159560981
- 35 USC 102 Novelty (BERT): 0.5675800246039034
- Combined Prediction Score: 0.6931670968208786
- Mean Citation Score: 298.173318
- Max Citation Score: 473.1609
- Similarity Product: 314.2108073761761

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test